These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 36414794
21. Safety, pharmacokinetics, and pharmacodynamics of efzimfotase alfa, a second-generation enzyme replacement therapy: phase 1, dose-escalation study in adults with hypophosphatasia. Dahir KM, Shannon A, Dunn D, Voegtli W, Dong Q, Hasan J, Pradhan R, Pelto R, Pan WJ. J Bone Miner Res; 2024 Sep 26; 39(10):1412-1423. PubMed ID: 39135540 [Abstract] [Full Text] [Related]
22. Status Epilepticus due to Asfotase Alfa Interruption in Perinatal Severe Hypophosphatasia. Ogawa E, Shimura K, Yoshihashi H, Miyama S. Pediatr Neurol; 2022 May 26; 130():4-6. PubMed ID: 35303588 [Abstract] [Full Text] [Related]
23. Gene therapy improves dental manifestations in hypophosphatasia model mice. Okawa R, Iijima O, Kishino M, Okawa H, Toyosawa S, Sugano-Tajima H, Shimada T, Okada T, Ozono K, Ooshima T, Nakano K. J Periodontal Res; 2017 Jun 26; 52(3):471-478. PubMed ID: 27561677 [Abstract] [Full Text] [Related]